Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Copyright © 2024 American Chemical Society
June 28, 2021 Cover
Volume 99, Issue 24
Pharmaceutical services companies like Seqens, Lonza, and Evonik make many of the biotech industry’s small-molecule drugs
Cover image:When biotechs need a molecule for drug trials or the market, they often turn to big pharmaceutical services firms
Credit: Mike Reddy
Volume 99 |
Issue 24
Quote of the Week
“Great drugs are developed on the backs of great relationships.”
Remote education inspires new ways to teach chemistry lab courses
The pandemic forced chemistry instructors to rethink how to teach the lab component of undergraduate chemistry classes
Italmatch: The making of an Italian chemical giant
A once-tiny producer of phosphorus for matches in Italy may soon have $1 billion in sales
-
Former OSHA head David Michaels calls for transformation of US worker safety
Agency’s longest-serving director would like to see companies mandated to ensure their production processes and products are not harmful
-
Synthesizing a natural product
Mithra chooses Seqens to scale up manufacturing of an estrogen found in nature
-
A long collaboration arrives at the production stage
Aurinia will use a dedicated Lonza plant to produce its new lupus nephritis drug
-
A small firm checks in at a big partner’s complex
Cassava picks Evonik to make the experimental Alzheimer’s disease treatment simufilam for Phase 3 clinical trials
ADVERTISEMENT
Science Concentrates
Peter Dervan named 2022 Priestley Medalist
Caltech researcher honored for pioneering contributions in chemical biology
Business & Policy Concentrates
- The US chemical industry will take until 2023 to recoup lost 2020 growth
- Indorama is in talks to buy Oxiteno
- US EPA to reexamine ethylene oxide risks
- Chemical Safety Board sends 2 staff to Chemtool plant after fire
- AI firm Insilico closes a $255 million financing round as it builds on discovery research
